drugset / Trial / NCT05650697

Topical CBD Scar Outcomes Study

NCT05650697

Phase 0 Not yet recruiting 22 enrolled University of Oklahoma
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to find out what effects (good and bad) that cannabidiol (CBD) has on scar healing and appearance in patients who have undergone paramedian forehead flap reconstruction.

Timeline

Start
2026-09
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified Topical

Indications

No indication recorded.